- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/68 - Hormone mélanotrope [MSH]
Détention brevets de la classe C07K 14/68
Brevets de cette classe: 119
Historique des publications depuis 10 ans
|
7
|
8
|
7
|
5
|
5
|
1
|
2
|
6
|
8
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Endevica bio, Inc. | 66 |
29 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2322 |
12 |
| Palatin Technologies, Inc. | 59 |
8 |
| Novo Nordisk A/S | 2292 |
8 |
| Rhythm Pharmaceuticals, Inc. | 96 |
6 |
| Ipsen Pharma S.A.S. | 376 |
5 |
| Board of Regents, The University of Texas System | 6177 |
4 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1041 |
4 |
| Intezyne Technologies, Inc. | 50 |
4 |
| Provincial Health Services Authority | 201 |
4 |
| Stc.unm | 657 |
4 |
| TXP Pharma GmbH | 11 |
4 |
| Genzyme Corporation | 1381 |
3 |
| The University of British Columbia | 1557 |
3 |
| The Regents of the University of Colorado, a body corporate | 2845 |
2 |
| Trustees of Tufts College | 995 |
2 |
| Tufts Medical Center, Inc. | 238 |
2 |
| The Regents of the University of Michigan | 5051 |
1 |
| The Trustees of the University of Pennsylvania | 4441 |
1 |
| Aileron Therapeutics, Inc. | 78 |
1 |
| Autres propriétaires | 12 |